Literature DB >> 6380502

Vascular serotonin receptors. Correlation with 5-HT1 and 5-HT2 binding sites.

S J Peroutka.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6380502     DOI： 10.1016/0006-2952(84)90704-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Contractions to 5-hydroxytryptamine in human coronary artery and human saphenous vein.

Authors:  M Borton; M Neligan; F Wood; P Dervan; K Goggins; J R Docherty
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

2.  Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat.

Authors:  J R Docherty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

3.  An examination of 5-hydroxytryptamine receptors in human saphenous vein.

Authors:  J R Docherty; L Hyland
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

4.  An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes.

Authors:  K G Charlton; R A Bond; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

5.  Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

6.  Cold-induced Raynaud's phenomenon ameliorated by intravenous administration of ketanserin: a double-blind cross-over study.

Authors:  H Baart de la Faille; H van Weelden; J D Banga; R G van Kesteren
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

7.  A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.

Authors:  W Feniuk; P P Humphrey; M J Perren; A D Watts
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

8.  Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle.

Authors:  Moo-Yeol Lee; Young-Ho Lee; Kyung-Min Lim; Seung-Min Chung; Ok-Nam Bae; Heon Kim; Choong-Ryeol Lee; Jung-Duck Park; Jin-Ho Chung
Journal:  Environ Health Perspect       Date:  2005-10       Impact factor: 9.031
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.